U.S. PHARMACOPEIA

Search USP29  
Simvastatin
Click to View Image
C25H3805 418.57

Butanoic acid, 2,2-dimethyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl ester, [1S-[1,3,7,8(2S*,4S*),8a]].
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-2-[(1S,2S,6R,8S,8R)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl]ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one [79902-63-9].
» Simvastatin contains not less than 98.0 percent and not more than 101.0 percent of C25H38O5, calculated on the dried basis. It may contain a suitable antioxidant.
Packaging and storage— Preserve in well-closed containers. Store between 15 and 30, or under refrigeration.
Identification—
Solution: 10 µg per mL.
Medium: acetonitrile.
Specific rotation 781S: between +285 and +298.
Test solution: 5 mg per mL, in acetonitrile.
Loss on drying 731 Dry it in vacuum at 60 for 3 hours: it loses not more than 0.5% of its weight.
Residue on ignition 281: not more than 0.1%.
Heavy metals, Method II 231: 0.002%.
Chromatographic purity—
Diluting solution— Prepare a solution of butylated hydroxytoluene in acetonitrile containing 0.5 mg per mL.
Standard solutions— Dissolve an accurately weighed quantity of USP Simvastatin RS in Diluting solution to obtain Standard solution A having a known concentration of about 0.2 mg per mL. Transfer 4.0, 2.0, and 1.0 mL of Standard solution A to separate 10-mL volumetric flasks, and dilute with Diluting solution to volume to obtain Standard solutions B, C, and D, respectively.
Test solution— Dissolve an accurately weighed quantity of simvastatin in Diluting solution to obtain a solution having a concentration of about 20 mg per mL.
Procedure— Separately apply 4-µL portions of each of the Standard solutions and the Test solution to a thin-layer chromatographic plate (see Chromatography 621) coated with a 0.25-mm layer of silica gel mixture, previously washed with methanol and air-dried. Dry the spots with the aid of a stream of nitrogen. Position the plate in a chromatographic chamber previously equilibrated with a solvent system consisting of a mixture of cyclohexane, chloroform, and isopropyl alcohol (5:2:1) containing 0.5 mg of butylated hydroxytoluene per mL, and develop the chromatogram until the solvent front has moved about three-quarters of the length of the plate. Remove the plate from the developing chamber, mark the solvent front, and allow the solvent to evaporate under a stream of nitrogen. Spray the plate with a mixture of methanol and sulfuric acid (8:2), heat at 110 for 30 minutes, and immediately examine the plate: no secondary spot in the chromatogram of the Test solution is greater in size or intensity than the principal spot from Standard solution B (0.4%), and the sum of all such secondary spots obtained from the Test solution is not greater than 1.0%.
Limit of lovastatin— From the chromatograms of the Assay preparation and the Standard preparation, obtained as directed in the Assay, calculate the percentage of lovastatin in the portion of Simvastatin taken by the formula:
10,000(C / W)(rU / rS),
in which C is the concentration, in mg per mL, of USP Lovastatin RS in the Standard preparation; W is the weight, in mg, of Simvastatin taken for the Assay preparation; and rU and rS are the lovastatin peak responses obtained from the Assay preparation and the Standard preparation, respectively: not more than 1% is found.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Assay—
Mobile phase— Prepare a filtered and degassed mixture of acetonitrile and dilute phosphoric acid (1 in 1000) (50:50). Make adjustments if necessary (see System Suitability under Chromatography 621).
Diluting solution— Prepare a mixture of acetonitrile and 0.01 M monobasic potassium phosphate (60:40), filter, and adjust with phosphoric acid to a pH of 4.0.
Standard preparation— Dissolve accurately weighed quantities of USP Simvastatin RS and USP Lovastatin RS in Diluting solution, and dilute quantitatively, and stepwise if necessary, to obtain a solution having known concentrations of about 0.3 mg per mL of USP Simvastatin RS and 0.003 mg per mL of USP Lovastatin RS.
Assay preparation— Transfer about 30 mg of Simvastatin, accurately weighed, to a 100-mL volumetric flask, and dissolve in and dilute with Diluting solution to volume.
Chromatographic system (see Chromatography 621)— The liquid chromatograph is equipped with a 238-nm detector and a 4.6- × 33-mm column that contains packing L1. The flow rate is about 3.0 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the relative retention times are about 0.65 for lovastatin and 1.0 for simvastatin; the resolution, R, between simvastatin and lovastatin is not less than 3.0; the column efficiency is not less than 2000 theoretical plates; the tailing factor is not more than 2.0; and the relative standard deviation for replicate injections is not more than 1.0%.
Procedure— Separately inject equal volumes (about 5 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the areas of the responses for the major peaks. Calculate the quantity, in mg, of C25H38O5 in the portion of Simvastatin taken by the formula:
100C(rU / rS),
in which C is the concentration, in mg per mL, of USP Simvastatin RS in the Standard preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Staff Liaison : Elena Gonikberg, Ph.D., Scientist
Expert Committee : (MDGRE05) Monograph Development-Gastrointestinal Renal and Endocrine
USP29–NF24 Page 1964
Pharmacopeial Forum : Volume No. 31(3) Page 792
Phone Number : 1-301-816-8251